Portfolio News

2026/02/10
MicroPort CardioFlow Announces Commercial Launch of FLEXIGO™ 3D delivery system for LBBAP in Europe and Australia
Shanghai, China - February 9, 2026 - MicroPort CardioFlow Medtech Corporation (02160.HK, “MicroPort CardioFlow”) announced today the commercial launch of the FLEXIGO™ 3D delivery system designed to support Left Bundle Branch Area Pacing (LBBAP) procedures, in Europe and Australia. LBBAP which leverages the heart’s natural conduction system, is increasingly recognized as the preferred approach to physiological pacing¹. The FLEXIGO™ 3D system is designed to support physicians in performing these procedures with controlled2,3,4 navigation and targeted LBBAP lead positioning5, facilitating consistent access to the desired anatomical region. Building on clinical validation and subsequent regulatory clearances, FLEXIGO™ 3D is now available for commercial use in Europe and Australia markets. The FLEXIGO™ 3D system combines a delivery catheter portfolio with eight available models and dedicated slitters, forming one cohesive solution designed to support precise LBBAP lead placement. The system is engineered to provide confidence and handling control2 throughout lead delivery, supporting physiological pacing across a variety of patient anatomies and lead profiles.  The FLEXIGO™ 3D system was developed under the Legacy Cardiac Rhythm Management (CRM) division of MicroPort and builds upon the company’s established leadership in physiological pacing solutions. In 2024, MicroPort CRM received expanded labeling for its ALIZEA™, BOREA™, and CELEA™ pacemaker families for Left Bundle Branch Area Pacing, reinforcing its commitment to advancing conduction system pacing technologies. MicroPort CardioFlow will continue to advance its globalization strategy, further supported by its recently announced strategic merger with MicroPort CRM. The combined capabilities of both companies aim to establish a comprehensive platform in structural heart, cardiac rhythm management (CRM), and heart failure, accelerating access to life-changing technologies worldwide. MicroPort CRM is now in the family of MicroPort CardioFlow.
Back